000 | 01975 a2200517 4500 | ||
---|---|---|---|
005 | 20250517203810.0 | ||
264 | 0 | _c20181121 | |
008 | 201811s 0 0 eng d | ||
022 | _a1399-3062 | ||
024 | 7 |
_a10.1111/tid.12874 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aMiller, Geraldine | |
245 | 0 | 0 |
_aA randomized, placebo-controlled phase I trial of live, attenuated herpes zoster vaccine in subjects with end-stage renal disease immunized prior to renal transplantation. _h[electronic resource] |
260 |
_bTransplant infectious disease : an official journal of the Transplantation Society _cJun 2018 |
||
300 |
_ae12874 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial, Phase I; Journal Article; Randomized Controlled Trial | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aAntibodies, Viral _xblood |
650 | 0 | 4 | _aDouble-Blind Method |
650 | 0 | 4 | _aDrug-Related Side Effects and Adverse Reactions |
650 | 0 | 4 | _aExanthema |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aHerpes Zoster _ximmunology |
650 | 0 | 4 |
_aHerpes Zoster Vaccine _xadministration & dosage |
650 | 0 | 4 |
_aHerpesvirus 3, Human _ximmunology |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aKidney Failure, Chronic _ximmunology |
650 | 0 | 4 |
_aKidney Transplantation _xadverse effects |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aNeuralgia, Postherpetic |
650 | 0 | 4 |
_aVaccination _xadverse effects |
650 | 0 | 4 |
_aVaccines, Attenuated _xadministration & dosage |
700 | 1 | _aSchaefer, Heidi | |
700 | 1 | _aYoder, Sandra | |
700 | 1 | _aMiller, Rachel | |
700 | 1 | _aWinokur, Patricia | |
700 | 1 | _aKotloff, Karen | |
700 | 1 | _aKlassen, David | |
700 | 1 | _aWierzbicki, Michael | |
700 | 1 | _aAmegashie, Cyrille | |
700 | 1 | _aEdwards, Kathryn | |
773 | 0 |
_tTransplant infectious disease : an official journal of the Transplantation Society _gvol. 20 _gno. 3 _gp. e12874 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1111/tid.12874 _zAvailable from publisher's website |
999 |
_c28152833 _d28152833 |